Flu & Viruses
-
Improved measure for long COVID
A new assessment tool will be the most thorough developed to date for long COVID, according to researchers from Birmingham. Read more
-
Telomere length associated with COVID-19 mortality
Telomeres may influence the severity of COVID-19 and the risk of dying from the disease, particularly in women, a European conference is to hear. Read more
-
Health worker tests positive for two COVID-19 variants in three weeks
A Spanish health worker tested positive for the Omicron COVID-19 variant 20 days after having the Delta variant – the shortest gap between infections yet to be recorded, it has been revealed. Read more
-
Make-up of SARS-CoV-2 outer envelope revealed
The molecular make-up of the fatty outer envelope of SARS-CoV-2 has been detailed for the first time, offering a new target for antivirals, British scientists have announced. Read more
-
Mystery of new child hepatitis outbreak
Investigators are trying to find the cause of a new kind of hepatitis that has affected 74 children this year. Read more
-
Single HPV jab ‘sufficient’
A single dose of the human papillomavirus vaccine gives as good protection as two doses, experts have ruled. Read more
-
Low heart risk from COVID jab
There is no significant rise in cases of myopericarditis after COVID-19 vaccination programmes, according to a new analysis. Read more
-
Community trial to test new antiviral
A new antiviral could become available in the community as part of a major trial, it was announced today. Read more
-
COVID-19 jeopardises tuberculosis progress
The COVID-19 pandemic has risked progress on the global control of tuberculosis, experts will warn today. Read more
-
WHO convoys restore HIV drugs to Ukraine
The relief of Kyiv has opened the way for a big drive to restore care for thousands of patients with HIV in Ukraine, the World Health Organization indicated today. Read more